Genelux Corporation (GNLX) Insider Trading

Over the last 3 months, GNLX insiders made 0 open-market buys and 5 sales, a net sale of -$48K (SEC Form 4). Over the last 6 months, 17 institutions increased and 16 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$48.2K
Insider trades by month Buys Sells
Dec
Mar
May
Jun
Jul
Aug
Context3-month price -12.1%Institutions reducing (13F)
DateInsiderTypeSharesPrice
Aug 4, 2026Yu Yongofficer: Chief Scientific OfficerSell653$2.94
Aug 4, 2026Cappello Josephofficer: Chief Technical OfficerSell653$2.95
Aug 4, 2026Zindrick Thomasofficer: President and CEOSell3,023$2.95
Jul 2, 2026Smither John WdirectorSell12,000$2.91
Jun 18, 2026Smither John WdirectorGrant28,409
Jun 18, 2026Smither John WdirectorGrant31,566$3.03
Jun 18, 2026Thomas JohndirectorGrant31,566$3.03
Jun 18, 2026Mirabelli MarydirectorGrant28,409
Jun 18, 2026Mirabelli MarydirectorGrant31,566$3.03
Jun 18, 2026Yu Yongofficer: Chief Scientific OfficerGrant119,318
Jun 18, 2026Pulisic Matthewofficer: Chief Financial OfficerGrant278,906
Jun 18, 2026Groen Ericofficer: General CounselGrant233,957
Jun 18, 2026Cappello Josephofficer: Chief Technical OfficerGrant174,841
Jun 18, 2026Tyree James LdirectorGrant28,409
Jun 18, 2026Tyree James LdirectorGrant31,566$3.03
Jun 18, 2026Zindrick Thomasofficer: President and CEOGrant730,601
Jun 18, 2026Thomas JohndirectorGrant28,409
Jun 4, 2026Smalling Ralphofficer: Head of RegulatorySell192$2.93
Jun 2, 2026Thomas JohndirectorSell10,000$2.98
May 12, 2026Smalling Ralphofficer: Head of RegulatorySell270$2.98
May 12, 2026Yu Yongofficer: Chief Scientific OfficerSell605$2.97
May 12, 2026Zindrick Thomasofficer: President and CEOSell2,798$2.94
May 12, 2026Cappello Josephofficer: Chief Technical OfficerSell605$2.97
Mar 26, 2026Cappello Josephofficer: Chief Technical OfficerSell906$2.42
Mar 26, 2026Smalling Ralphofficer: Head of RegulatorySell345$2.42
Mar 26, 2026Smalling Ralphofficer: Head of RegulatorySell240$2.51
Mar 26, 2026Yu Yongofficer: SVP, Clinical DevelopmentSell906$2.42
Mar 26, 2026Zindrick Thomasofficer: President and CEOSell3,582$2.42
Mar 3, 2026Thomas JohndirectorSell10,000$2.90
Jan 7, 2026Litten Jasonofficer: Chief Medical OfficerGrant275,000$4.55

Source: GNLX SEC Form 4 filings, latest Aug 4, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their GNLX positions over the last 6 months (SEC Form 13F).

Increased
17
New positions
12
Reduced
16
Sold out
72
Largest moves
InstitutionActionSharesFiled
WOODWARD DIVERSIFIED CAPITAL, LLCIncreased2.1MApr 24, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1.7MMay 15, 2026
BLEICHROEDER LPIncreased1.4MMay 14, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased454KMay 15, 2026
BLACKROCK, INC.Increased406KMay 13, 2026
BANK OF AMERICA CORP /DE/Reduced324KMay 18, 2026
FLPUTNAM INVESTMENT MANAGEMENT COReduced281KMay 5, 2026
VANGUARD FIDUCIARY TRUST CONew Position252KMay 8, 2026
CM MANAGEMENT, LLCNew Position250KMay 8, 2026
GOLDMAN SACHS GROUP INCIncreased184KMar 25, 2026
NORTHERN TRUST CORPIncreased164KMay 14, 2026
PROVIDENT WEALTH MANAGEMENT, LLCUnchanged156KApr 17, 2026
STATE STREET CORPUnchanged146KMay 15, 2026
LPL FINANCIAL LLCIncreased139KMay 6, 2026
UBS GROUP AGIncreased123KMay 5, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.